MOLM-13 Cells
USUSD$375.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | The MOLM-13 cell line is a human acute myeloid leukemia (AML) cell line, originally derived from a patient diagnosed with AML-M5a (acute monocytic leukemia, FAB classification). This line was established at the time of disease relapse, following prior progression from myelodysplastic syndrome (MDS). MOLM-13 cells harbor the MLL-AF9 gene fusion resulting from an insertion, ins(11;9)(q23;p22p23), and exhibit additional chromosomal abnormalities such as trisomy 8, a common feature associated with AML. In terms of phenotypic characteristics, MOLM-13 cells express myeloid and monocyte-associated markers including CD33, CD13, and CD15. However, they lack expression of CD34, a marker of hematopoietic stem and progenitor cells, distinguishing them from other leukemia subtypes. MOLM-13 cells also display monoblastoid morphology with fine chromatin and prominent nucleoli. Functionally, they are capable of differentiation into macrophage-like cells upon exposure to specific cytokines such as interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α), which also enhance expression of myelomonocytic markers. MOLM-13 serves as a critical model for studying leukemogenesis, particularly mechanisms underlying MLL-rearranged leukemias. It is also widely used in preclinical research, including the evaluation of novel therapies such as CD70-specific CAR-T cells, which have demonstrated efficacy against MOLM-13 in vitro and in xenograft models. This makes MOLM-13 an invaluable tool for exploring targeted therapeutic approaches for high-risk AML. |
|---|---|
| 生物體 | Human |
| 組織 | Peripheral blood |
| 疾病 | Adult acute myeloid leukemia |
| 同義詞 | MOLM13, Molm13, Molm 13 |
特徵
| 年齡 | 20 years |
|---|---|
| 性別 | Male |
| 族裔 | Japanese |
| 形態學 | Lymphoblast-like |
| 生長特性 | Suspension |
監管數據
| 引用 | MOLM-13 (Cytion catalog number 305393) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_2119 |
生物分子資料
| 抗原表達 | CD3 -, CD4 +, CD14 -, CD15 +, CD19 -, CD33 +, CD34 -, cy CD68 +, HLA-DR - |
|---|---|
| 突變譜 | Mutation: FLT3, unexplicit, internal tandem duplication; Gene fusion: KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 播種密度 | Maintain culture between 4 x 105 to 2 x 106 cells/mL |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305393-261225 | 分析證明書 | 11. Feb. 2026 | 305393 |